Vivalis acquires HUMALYS - MarketLine Financial Deals

Vivalis acquires HUMALYS

Vivalis acquires HUMALYS - MarketLine Financial Deals
Vivalis acquires HUMALYS
Published Jan 11, 2010
2 pages — Published Jan 11, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report


Vivalis SA, a biopharmaceutical company focused on viral diseases, has acquired HUMALYS SAS, a biotech research and development company.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Vivalis acquires HUMALYS" Jan 11, 2010. Alacra Store. May 21, 2018. <>
MarketLine Financial Deals. (2010). Vivalis acquires HUMALYS Jan 11, 2010. New York, NY: Alacra Store. Retrieved May 21, 2018 from <>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.